Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of

Maria R Farcet1, Jens Modrof1, Philip O Rabel1

  • 1Global Pathogen Safety, Vienna, Austria.

Transfusion
|December 12, 2018
PubMed
Abstract

Insights

Hyper-attenuated poliovirus strains (S19) can replace wild-type poliovirus for immunoglobulin lot release testing. This ensures continued safe use of poliovirus while supporting global eradication efforts.

Area of Science:

  • Virology
  • Immunology

Background:

  • Wild-type poliovirus eradication is imminent, necessitating strict containment or discontinuation of laboratory use.
  • US regulations require replicating poliovirus for immunoglobulin lot release testing.
  • Investigating S19 poliovirus strains as alternatives to wild-type virus is crucial.

Purpose of the Study:

  • To assess the suitability of S19 hyper-attenuated poliovirus strains for immunoglobulin lot release assays.
  • To determine if S19 strains can serve as safe and effective replacements for wild-type poliovirus.

Main Methods:

  • S19 poliovirus strains were propagated under good virological practices.
  • Massively parallel sequencing confirmed the S19 hyper-attenuated genotype.
  • The attenuated phenotype was validated in a sensitive mouse model.

Main Results:

  • Propagation and characterization of S19 poliovirus stocks were successful.
  • S19 strains demonstrated an attenuated phenotype in vivo.
  • S19 and wild-type polioviruses showed equivalent performance in lot release assays.

Conclusions:

  • Hyper-attenuated S19 poliovirus stocks are suitable alternatives for immunoglobulin lot release testing.
  • These characterized S19 stocks reconcile containment measures with essential poliovirus use.
  • Deployment of S19 strains supports both poliovirus eradication and ongoing laboratory needs.

Related Concept Videos

Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.4K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
342
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
2.7K
Null and Alternative Hypotheses01:16

Null and Alternative Hypotheses

The actual hypothesis testing begins by considering two hypotheses. They are termed  the null hypothesis and the alternative hypothesis. These hypotheses contain opposing viewpoints.
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As  a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...
12.7K